Treatment with radioactive ⁸⁹strontium for patients with bone metastases from prostate cancer

This publication has 37 references indexed in Scilit:

• An examination of nursing attitudes and pain management practices [see comments]
  Cancer Practice, 1998
• Selective accumulation of strontium-89 in metastatic deposits in bone
  Nuclear Medicine Communications, 1995
• A direct measurement of strontium-89 activity in bone metastases
  Nuclear Medicine Communications, 1995
• A retrospective analysis of the cost effectiveness of treatment with Metastron?? (89Sr-chloride) in patients with prostate cancer metastatic to bone
  Nuclear Medicine Communications, 1994
• Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?
  Clinical Oncology, 1992
• Strontium-89 chloride for pain palliation in prostatic skeletal malignancy
  The British Journal of Radiology, 1991
• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991
• Correlation of patient and caregiver ratings of cancer pain
  Journal of Pain and Symptom Management, 1991
• A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases
  Clinical Oncology, 1989
• METABOLIC STUDIES ON NEOPLASM OF BONE WITH THE AID OF RADIOACTIVE STRONTIUM*
  The Lancet Healthy Longevity, 1942